STOK
Stoke Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.51 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: 66.7% Strong Buy and 33.3% Buy across six recommendations, with top analysts posting 75‑80% win rates. Fund‑flow score is 7.65 (good), showing medium and large inflows positive while smaller segments remain negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-17
InstitutionNeedham
Times predicted4
Historical Win Rate75.0%
What is the analyst consensus for STOK?
- STOK holds a Bullish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.51/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
